1. 34TiP Prospective analysis of intestinal microbiome and autoimmune panels as predictors of toxicity in immunoncology patients (INSPECT-IO Study). (December 2022) Authors: Salawu, A.T.; Genta, S.; Spiliopoulou, P.; Yee, N.; M. Ye, ; Ly, L.; Taylor, R.; Vornicova, O.; Abdul Razak, A.R.; Bedard, P.L.; Wang, L.; Siu, L.L.; Coburn, B.; Spreafico, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 9P Early circulating tumor DNA (ctDNA) kinetics and gene expression analysis to predict treatment outcomes with anti-PD-1 therapy. (December 2022) Authors: Sanz Garcia, E.; Laliotis, G.; Avery, L.; Spreafico, A.; Hansen, A.R.; Eng, L.; Singaravalan, N.; Willingham, S.; Liu, M.; Soleimani, S.; Pugh, T.; Bratman, S.; Siu, L.L. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characterizing mechanisms of resistance to BRAF and MEK inhibitors in cancers with Class 2 BRAF mutations: uncovering novel therapeutic opportunities. (October 2022) Authors: Riaud, M.; Biondini, M.; Cianfarano, E.; Rousselle, E.; Maxwell, J.; Soria-Bretones, I.; Tai, P.; Wang, H.; Siegel, P.M.; Cescon, D.W.; Spreafico, A.; Rose, A.A.N. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials. (January 2019) Authors: Kanjanapan, Y.; Day, D.; Butler, M.O.; Wang, L.; Joshua, A.M.; Hogg, D.; Leighl, N.B.; Razak, A.R. Abdul; Hansen, A.R.; Boujos, S.; Chappell, M.; Chow, K.; Sherwin, B.; Stayner, L.-A.; Soultani, L.; Zambrana, A.; Siu, L.L.; Bedard, P.L.; Spreafico, A. Journal: European journal of cancer Issue: Volume 107(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HPV Status Improves Classification of Head and Neck Gray Zone Cancers. (July 2019) Authors: Ren, J.; Xu, W.; Su, J.; Ren, X.; Bender, N.; Habbous, S.; de Almeida, J.R.; Goldstein, D.P.; Cheng, D.; Chen, Z.; Mirshams, M.; Rahini, M.; Huang, S.H.; Spreafico, A.; Hansen, A.; Kim, J.; Waldron, J.; Perez-Ordonez, B.; Zhao, Y.; Hung, R. Journal: Journal of dental research Issue: Volume 98:Number 8(2019) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HPV Status Improves Classification of Head and Neck Gray Zone Cancers. (July 2019) Authors: Ren, J.; Xu, W.; Su, J.; Ren, X.; Bender, N.; Habbous, S.; de Almeida, J.R.; Goldstein, D.P.; Cheng, D.; Chen, Z.; Mirshams, M.; Rahimi, M.; Huang, S.H.; Spreafico, A.; Hansen, A.; Kim, J.; Waldron, J.; Perez-Ordonez, B.; Zhao, Y.; Hung, R. Journal: Journal of dental research Issue: Volume 98:Number 8(2019) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O1.1 Clinical presentation and outcome of HPV-positive nasopharyngeal carcinoma in a North American cohort. (November 2022) Authors: Huang, S.; Jacinto, J.; O'Sullivan, B.; Su, J.; Xu, W.; Spreafico, A.; Goldstein, D.; Waldron, J. Journal: Oral oncology Issue: Volume 134(2022)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PH-0051 Outcomes after definitive (C)RT in HPV+ OPC: Largescale comparison of two population-based cohorts. (August 2021) Authors: Lassen, P.; Huang, S.H.; Su, J.; O'Sullivan, B.; Waldron, J.; Andersen, M.; Primdahl, H.; Johansen, J.; Andrup Kristensen, C.; Andersen, E.; Eriksen, J.; Rønn Hansen, C.; Alsner, J.; Lilja-Fisher, J.; Bratman, S.V.; Ringash, J.; Kim, J.; Hope, A.; Spreafico, A.; de Almeida, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck. (September 2020) Authors: Day, D.; Prawira, A.; Spreafico, A.; Waldron, J.; Karithanam, R.; Giuliani, M.; Weinreb, I.; Kim, J.; Cho, J.; Hope, A.; Bayley, A.; Ringash, J.; Bratman, S.V.; Jang, R.; O'Sullivan, B.; Siu, L.L.; Hansen, A.R. Journal: Oral oncology Issue: Volume 108(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PV-0200 Accelerated- vs chemo-radiation as organ sparing strategies for laryngeal/hypopharyngeal carcinoma. (April 2019) Authors: Elamir, A.M.; Huang, S.; Xu, W.; Yu, M.; Spreafico, A.; Bayley, A.; Bratman, S.V.; Cho, J.; Giuliani, M.; Hope, A.; Kim, J.; O'Sullivan, B.; Ringash, J.; De Almeida, J.R.; Chepeha, D.; Goldstein, D.; Irish, J.; Waldron, J.; Hosni, A. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗